Home › Companies › IOVANCE BIOTHERAPEUTICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and IOVANCE BIOTHERAPEUTICS INC.’s Form 8-K, filed June 10, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 10, 2025: 11 items on IOVANCE BIOTHERAPEUTICS INC.’s Form 8-K, filed June 10, 2025: 4 approved · 7 passed (calculated).
Significant dissent: 1 director (43.4% against).
Notable dissent: 1 director (17.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore IOVANCE BIOTHERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are IOVANCE BIOTHERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Dukes | 142,089,795 | 30,706,393 | 1,322,491 | -- | 80,162,659 | 82% | Passed (calculated) | — |
| Elect Director: Dr. Countouriotis | 97,767,917 | 75,070,020 | 1,280,742 | -- | 80,162,659 | 57% | Passed (calculated) | — |
| Elect Director: Mr. Maynard | 166,367,869 | 6,453,538 | 1,297,272 | -- | 80,162,659 | 96% | Passed (calculated) | — |
| Elect Director: Mr. Rothbaum | 166,890,379 | 6,038,284 | 1,190,016 | -- | 80,162,659 | 97% | Passed (calculated) | — |
| Elect Director: Dr. Vogt | 165,079,137 | 8,467,205 | 572,337 | -- | 80,162,659 | 95% | Passed (calculated) | — |
| Elect Director: Dr. Weiser | 165,295,535 | 7,540,940 | 1,282,204 | -- | 80,162,659 | 96% | Passed (calculated) | — |
| Elect Director: Ms. Yarno | 166,781,324 | 5,674,432 | 1,662,923 | -- | 80,162,659 | 97% | Passed (calculated) | — |
| This proposal was approved with 158,778,895 "FOR" votes, 14,490,865 "AGAINST" votes and 848,919 "ABSTAIN" votes | 158,778,895 | 14,490,865 | 848,919 | -- | 80,162,659 | 92% | Approved | — |
| This proposal was approved with 248,444,246 "FOR" votes, 4,930,624 "AGAINST" votes and 906,468 "ABSTAIN" votes | 248,444,246 | 4,930,624 | 906,468 | -- | 0 | 98% | Approved | — |
| This proposal was approved with 160,920,940 "FOR" votes, 12,607,644 "AGAINST" votes and 590,095 "ABSTAIN" votes | 160,920,940 | 12,607,644 | 590,095 | -- | 80,162,659 | 93% | Approved | — |
| This proposal was approved with 163,851,673 "FOR" votes, 9,804,728 "AGAINST" votes and 462,278 "ABSTAIN" votes | 163,851,673 | 9,804,728 | 462,278 | -- | 80,162,659 | 94% | Approved | — |
Source: IOVANCE BIOTHERAPEUTICS INC., Form 8-K, filed with the SEC on June 10, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
265 asset managers disclosed a vote on at least one IOVANCE BIOTHERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IOVANCE BIOTHERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
57% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Athena Countouriotis, M.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Countouriotis”): 97,767,917 for, 75,070,020 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 57% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 6,093,079 for, 48,604,029 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 101 | 27,857,904 | 0 | 0 | Against |
| BlackRock | 0 | 7,151,892 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 4,081,508 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 2,430,276 | 0 | 0 | Against |
| Principal | 611 | 2,094,700 | 0 | 0 | Against |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 0 | 817,117 | 0 | 0 | Against |
| Equitable | 0 | 610,583 | 0 | 0 | Against |
| Fidelity | 0 | 305,709 | 0 | 0 | Against |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 275,886 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 270,099 | 0 | 0 | Against |
| State Street | 738 | 269,003 | 0 | 0 | Against |
| Virtus | 0 | 177,635 | 0 | 0 | Against |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0 | 160,900 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 157,696 | 0 | 0 | Against |
| Guggenheim | 0 | 150,408 | 0 | 0 | Against |
| John Hancock | 0 | 147,607 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 145,798 | 0 | 0 | Against |
| ProShares | 0 | 145,497 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 140,283 | 0 | 0 | Against |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Vogt”): 165,079,137 for, 8,467,205 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 54,697,108 for, 0 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: lain Dukes, D. Phil.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Dukes”): 142,089,795 for, 30,706,393 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 41,893,482 for, 12,803,626 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,855,791 | 2,214 | 0 | 0 | For |
| BlackRock | 408,187 | 6,743,705 | 0 | 0 | Mixed |
| Delaware/Macquarie | 0 | 4,081,508 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 2,130 | 608,453 | 0 | 0 | Against |
| Fidelity | 211,989 | 93,720 | 0 | 0 | Mixed |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 75,186 | 200,700 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 0 | 270,099 | 0 | 0 | Against |
| State Street | 1,062 | 268,679 | 0 | 0 | Against |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 129,198 | 0 | 0 | Against |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Weiser”): 165,295,535 for, 7,540,940 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 54,511,283 for, 185,825 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,855,791 | 2,214 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Ryan Maynard
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Maynard”): 166,367,869 for, 6,453,538 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 54,542,338 for, 154,770 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wayne P. Rothbaum
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Rothbaum”): 166,890,379 for, 6,038,284 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 54,542,338 for, 154,770 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wendy Yarno
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Ms. Yarno”): 166,781,324 for, 5,674,432 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 54,697,108 for, 0 against, 27,255 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 12,500,000 shares; and
The 65 asset managers below reported 54,619,134 for, 77,974 against, 27,255 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,736 | 5 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR 2020 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF THE COMPANY'S COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 1,000,000 SHARES.
The 65 asset managers below reported 54,697,108 for, 27,255 against, 0 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
97% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,855,777 | 2,228 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 352,793 | 257,790 | 0 | 0 | Mixed |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,343 | 398 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 131,800 | 0 | 0 | Against |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 54,185,930 for, 511,178 against, 27,255 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | 24,417,103 | 0 | 0 | 0 | For |
| Invenomic Capital Management LP | 6,574,399 | 0 | 0 | 0 | For |
| BlackRock | 6,033,912 | 43,272 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 4,505,363 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 3,914,644 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,413,911 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 3,032,209 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 3,010,085 | 0 | 0 | 0 | For |
| State Street | 2,698,874 | 1,058 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 1,906,962 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,639 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 1,298,111 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 1,260,000 | 0 | 0 | Against |
| Northern Trust | 1,242,199 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,124,195 | 0 | 0 | 0 | For |
| APIS CAPITAL ADVISORS, LLC | 1,098,130 | 0 | 0 | 0 | For |
| Nuveen | 836,018 | 0 | 0 | 0 | For |
| UBS | 0 | 774,375 | 0 | 0 | Against |
| Vanguard | 758,768 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 705,319 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 647,492 | 0 | 0 | 0 | For |
| Allianz | 0 | 606,361 | 0 | 0 | Against |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 539,703 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 504,640 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 476,611 | 0 | 0 | Against |
Institutional-manager reports, all 215 managers: 74,550,881 for, 3,961,348 against, 161,143 abstained, 129,705 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
The 64 asset managers below reported 54,697,108 for, 0 against, 27,255 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 27,858,005 | 0 | 0 | 0 | For |
| BlackRock | 7,151,892 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 4,081,508 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 3,280,195 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,430,276 | 0 | 0 | 0 | For |
| Principal | 2,095,311 | 0 | 0 | 0 | For |
| Charles Schwab | 1,871,604 | 0 | 0 | 0 | For |
| TIAA | 817,117 | 0 | 0 | 0 | For |
| Equitable | 610,583 | 0 | 0 | 0 | For |
| Fidelity | 305,709 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 302,872 | 0 | 0 | 0 | For |
| Lincoln Financial | 275,886 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 270,099 | 0 | 0 | 0 | For |
| State Street | 269,741 | 0 | 0 | 0 | For |
| Virtus | 177,635 | 0 | 0 | 0 | For |
| Global X | 162,142 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 160,900 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 157,696 | 0 | 0 | 0 | For |
| Guggenheim | 150,408 | 0 | 0 | 0 | For |
| John Hancock | 147,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 145,798 | 0 | 0 | 0 | For |
| ProShares | 145,497 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,283 | 0 | 0 | 0 | For |
| Aberdeen | 131,800 | 0 | 0 | 0 | For |
| Northern Trust | 129,198 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 333,934,387 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.34% |
| 2 | BlackRock | 2.14% |
| 3 | Delaware/Macquarie | 1.22% |
| 4 | NORTHERN LIGHTS FUND TRUST II | 0.98% |
| 5 | T. Rowe Price | 0.73% |
| 6 | Principal | 0.63% |
| 7 | Charles Schwab | 0.56% |
| 8 | TIAA | 0.24% |
| 9 | Equitable | 0.18% |
| 10 | Fidelity | 0.09% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MHR FUND MANAGEMENT LLC | 7.31% |
| 2 | Invenomic Capital Management LP | 1.97% |
| 3 | BlackRock | 1.82% |
| 4 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1.35% |
| 5 | Hood River Capital Management LLC | 1.17% |
| 6 | T. Rowe Price | 1.02% |
| 7 | Palo Alto Investors LP | 0.91% |
| 8 | PRINCIPAL GLOBAL INVESTORS | 0.90% |
| 9 | State Street | 0.81% |
| 10 | Soleus Capital Management, L.P. | 0.57% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| New York, NY | 30,000,000 | 8.98% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Wayne Rothbaum | 30,000,000 | 8.98% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| Vanguard Group | 27,777,778 | 8.32% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 24,314,578 | 7.28% | Form 13F, quarter ended March 31, 2025 |
| Malvern, PA | 22,812,820 | 6.83% | Proxy statement (DEF 14A), proxy filed April 28, 2025 |
| State Street | 11,041,322 | 3.31% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 5,968,298 | 1.79% | Form 13F, quarter ended March 31, 2025 |
| Goldman Sachs | 5,571,902 | 1.67% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 4,018,374 | 1.20% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 3,511,400 | 1.05% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 333,934,387 shares outstanding, as reported by IOVANCE BIOTHERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At IOVANCE BIOTHERAPEUTICS INC.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 265 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,301 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IOVANCE BIOTHERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding advisory vote, the compensation of our named executive officers. — the reporting funds and managers cast 97% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IOVANCE BIOTHERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
IOVANCE BIOTHERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “IOVANCE BIOTHERAPEUTICS (IOVA) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/iovance-biotherapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.